2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2603 | Spebrutinib | CC-292,LMK-435,AVL-292 | Src , BTK |
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. | |||
T14357 | Spebrutinib besylate | CC-292 (besylate),AVL-292 (benzenesulfonate) | BTK |
Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s). |